Evidence map›Paper›PMID 21647373›Full record

ArticlePloS one2011

Rapid reactivation of extralymphoid CD4 T cells during secondary infection.

Timothy J Chapman, Kris Lambert, David J Topham

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. T helper 1 effector memory CD4Cell reports · 2023
    Article
  6. Local memory CD4 T cell niches in respiratory viral infection.The Journal of experimental medicine · 2021
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Timothy J ChapmanDepartment of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, Aab Institute of Biomedical Sciences, University of Rochester, Rochester, New York, United States of America.
Kris Lambert
David J Topham
University of Rochester · US

Funding

Training Program in Viral Diseases,Vaccines/ BiodefenseT32AI007169 · NIAID · UNIVERSITY OF ROCHESTER · PI REICHMAN, RICHARD C. · 1985 to 2007
$2.4M
Pivotal role of VLA-1 in CD8 T cell retention &survivalR01AG021970 · NIA · UNIVERSITY OF ROCHESTER · PI TOPHAM, DAVID JAMES · 2003 to 2007
$1.6M
NIAID NIH HHS 2T32AI007169NIAID NIH HHS HHSN266200700008CNIAID NIH HHS N01 AI050020NIAID NIH HHS N01-AI50020NIAID NIH HHS T32 AI007169NIA NIH HHS R01 AG021970NIA NIH HHS R01-AG021970
6 · The paper itself

Abstract

After infection, extralymphoid tissues are enriched with effector and memory T cells of a highly activated phenotype. The capacity for rapid effector cytokine response from extralymphoid tissue-memory T cells suggests these cells may perform a 'sentinel' function in the tissue. While it has been demonstrated that extralymphoid CD4+ T cells can directly respond to secondary infection, little is known about how rapidly this response is initiated, and how early activation of T cells in the tissue may affect the innate response to infection. Here we use a mouse model of secondary heterosubtypic influenza infection to show that CD4(+) T cells in the lung airways are reactivated within 24 hours of secondary challenge. Airway CD4(+) T cells initiate an inflammatory cytokine and chemokine program that both alters the composition of the early innate response and contributes to the reduction of viral titers in the lung. These results show that, unlike a primary infection, extralymphoid tissue-memory CD4(+) T cells respond alongside the innate response during secondary infection, thereby shaping the overall immune profile in the airways. These data provide new insights into the role of extralymphoid CD4(+) T cells during secondary immune responses.

Indexed as

AnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteCD4-Positive T-LymphocytesCD69 AntigensCell CountCell ProliferationChemokinesImmunity, InnateInflammationInfluenza A virusLectins, C-TypeLungMicePhenotypeTime FactorsAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensChemokinesLectins, C-Type

Identifiers

PMID21647373
PMCPMC3103554
OpenAlexW2030951903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.